Back
Amgen Inc. (AMGN)
BiotechnologyAMGN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$363.37
−0.06%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$14.23
ROE
101.3%
Gross margin
71.4%
Debt/Equity
6.24x
Revenue growth
5.8%
Amgen Inc. — company intelligence
Earnings surprises
Q1 2026$5.15 vs $4.85 est+6.1%
Q4 2025$5.29 vs $4.83 est+9.6%
Q3 2025$5.64 vs $5.11 est+10.3%
Q2 2025$6.02 vs $5.39 est+11.6%
Insider activity · 90 days
36 buys43 sellsnet +233,991 shares
ECKERT ROBERTBuy 665 · May 19, 2026
Druker BrianBuy 665 · May 19, 2026
Drake Michael VBuy 665 · May 19, 2026
Recent SEC filings
4 — Insider transaction reportMay 21, 2026
4 — Insider transaction reportMay 21, 2026
4 — Insider transaction reportMay 21, 2026
Latest news
Truist Raises its Price Target on Amgen (AMGN) — Yahoo · 1d ago
Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings? — Yahoo · 1d ago
Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $333 — Benzinga · 2d ago
Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus — Yahoo · 3d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Amgen Inc.
Weekly undervalued picks (like AMGN)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.